Nutrient Regulation of Gene Expression porter (GLUTZ) that is constitutively present on the plasma membrane [Z]; (ii) in the adipocyte, glucose is phosphorylated by hexokinase (hexokinase 11) whereas, in the liver, it is phosphorylated by glucokinase (hexokinase IV) which requires insulin for its expression [3, 4] .
Fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC) are among the key enzymes of lipogenesis. In the rat, the hepatic synthesis of FAS is linked to the nutritional conditions in both the liver and adipose tissue. The amount of protein is high when animals are fed on a diet rich in carbohydrate [5, 6] . The increase in FAS synthesis observed when a starved animal is refed a high-carbohydrate diet is preceded by an increase in its mRNA [7, 8] and the rate of transcription of its gene [9, 10] . We have studied the signals involved in the stimulation of lipogenic enzyme expression by carbohydrates.
In vitro evidence from studies in suckling rats that lipogenic enzyme expression is controlled by glucose Suckling rats are fed on a diet rich in fat (69% of calories) and poor in carbohydrate (less than lo%), i.e. the milk [ 113. At weaning the rat is fed on laboratory chow which is a high-carbohydrate low-fat diet. Lipogenic activity is exceedingly low in the liver and adipose tissue of the suckling rat [ 1 1 -141 but greatly increases at weaning [ 
13,141.
This is due to enhanced activity of the enzymes of the lipogenic and pentose phosphate pathway, ACC, FAS, ATP citrate-lyase, glucose-6-phosphate dehydrogenase (G-6-PDH) and 'malic' enzyme. This phenomenon is preceded by an increase in the amount of the specific mRNAs (reviewed in [ll]). Weaning on to a high-fat diet prevents these changes, suggesting that they result from the change in diet rather than from the developmental stage [ 15-17]. Finally, giving a single carbohydrate meal to suckling rats, which increases both plasma glucose and insulin, is sufficient to induce in a few hours FAS and ACC mRNA in both liver and adipose tissue [ 
16,171.
In vitro studies on adipose tissue from suckling rats A 6 h culture of adipose tissue explants of 19-day-old suckling rats in the presence of glucose and insulin strongly increases the FAS and ACC mRNA contents to levels similar to those obtained in 30-day-old rats weaned on to a high-carbohydrate diet [ 181. Moreover, this effect is abolished by actinomycin D, suggesting that it results from the activation of transcription [19] . Whereas insulin alone in the presence of lactate as a substrate has no effect on ACC and FAS mRNA contents, glucose alone is able to increase FAS and ACC mRNA in a dosedependent manner and this effect is strongly potentiated by insulin. Maximal effects of glucose are obtained for a glucose concentration of 20 mM [18] . Thus in adipose tissue, glucose controls the expression of FAS and ACC, and insulin has only a potentiating role.
In vitro studies on isolated hepatocytes from suckling rats
Similar experiments have been performed on cultured hepatocytes from suckling rats [ZO] .
Again, the presence of insulin and 20 mM glucose in the culture medium increases the FAS mRNA content, an effect detectable after 32 h of culture and peaking after 48 h. Maximal induction requires the concomitant presence of dexamethasone and tri-iodothyronine in addition to insulin. Hormones have no effect in the absence of glucose (presence of lactate in the culture medium). However, in contrast with the studies on adipose tissue, glucose alone is unable to increase FAS mRNA content. Nevertheless, if hepatocytes are cultured for 48 h in the presence of hormones and then 20 mM glucose is added, FAS expression is greatly increased after 6 h of culture. This latter phenomenon does not require the continuous presence of hormones. Finally, the glucose effect is clearly concentration-dependent. Thus, in hepatocytes, as in adipocytes, the presence of glucose is an absolute requirement for the expression of FAS. However, in contrast with adipose tissue, various hormones (especially insulin) are essential to induce a factor necessary for the glucose effect.
In conclusion, these in vitm studies have demonstrated that elevated glucose concentrations are required to induce abundant expression of FAS both in adipose tissue and liver. Hormones, especially insulin, seem to have only an indirect role (see below), and insulin alone is unable to induce strong expression of the FAS gene in liver and adipose tissue.
Metabolism of glucose in order to increase lipogenic enzyme expression
The obvious question which arises when considering the effect of glucose concerns the nature of the molecule that acts as a signal to
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I996 increase gene expression. Is it glucose itself or one of its metabolites and, if it is the latter, which one?
In adipose-tissue explants, 3-0-methylglucose, a glucose analogue that is transported into the cell but is not phosphorylated by hexokinase, is unable to induce the expression of FAS and ACC [18] . In suckling rat hepatocytes, the glucose phosphorylation rate is extremely low since glucokinase, the liver-type hexokinase, is not expressed, and glucose 6-phosphate concentrations (taken as an index of glucose metabolism) are barely detectable even in the presence of 20 mM glucose. In these conditions, glucose is adipose tissue (probably through its stimulatory effect on glucose-transport rate), as evidenced by higher glucose 6-phosphate concentrations for similar glucose concentrations when insulin is present, it could explain why insu!in has a potentiating effect on FAS expression in adipocytes. The requirement of glucose metabolism for an effect on gene transcription has also been described for the ACC gene in a pancreatic p-cell line (INS-1) [22] which displays a welldifferentiated /3-cell phenotype [23] , including the capacity to secrete insulin in response to physiological glucose concentrations and the strong expression of glucokinase [24] . Glucose causes a rapid (4 h) dose-dependent increase in glucose 6-phosphate concentration and insulin secretion. Glucose-induced ACC expression and insulin secretion are inhibited by mannoheptulose and glucosamine which are known inhibitors of glucokinase. Finally ACC expression is not induced by 3-0-methylglucose or 6-deoxyglucose, glucose analogues that are not phosphorylated.
An interesting comparison can be made with the L-pyruvate kinase (L-PK) gene, another induced by replacing hormones and glucose by lactate, a second induction by reintroducing glucose into the culture medium is much more rapid (24 h). All these results are consistent with the idea that, in order for glucose to achieve its effect, glucokinase must be induced first by the presence of hormones and, once induced, allows a rapid effect of glucose through its metabolization. Moreover, glucose-induced expression of L-PK is independent of the presence of insulin in a hepatoma cell line that does not express glucokinase but a constitutive hexokinase [27] . It has been shown by the group of Van Schaftingen [28, 29] that fructose at minute concentrations is able to activate glucokinase activity by relieving the effect of an inhibitory protein. In primary cultures of fed rat hepatocytes which still retain an appreciable amount of glucokinase activity, fructose at 0.2 mM has no effect by itself on glucose 6-phosphate concentration but potentiates the increase seen in the presence of 20 mM glucose and in the absence of insulin [30] . Accordingly, fructose at 0.2 mM has no effect by itself on a reporter gene driven by the L-PK promoter but strongly potentiates the effect of 20 mM glucose in the absence of insulin. Finally cotransfection of the L-PK construct together with an expression vector of glucokinase is also able to confer an insulin-independent glucose response in cultured hepatocytes [30] .
Expression of L-PK has also been studied in the pancreatic INS-1 p-cell line. Glucose is able to induce L-PK expression in a concentrationdependent manner and its effect is inhibited by mannoheptulose, an inhibitor of glucokinase Thus the bulk of these studies indicates that in order for glucose to stimulate the expression of this class of genes, it must be metabolized. 
Which metabolite(s) is (are) likely candidate(s) to act as a signal for increased expression of lipogenic and glycolytic enzymes?
For a metabolite to qualify as a signal, its concentration must vary in proportion to the extracellular glucose concentration, since the glucose effect on gene expression is concentrationdependent. Usually, in metabolic pathways, one can differentiate between enzymes that are nonequilibrium and those that are near-equilibrium [31] . A non-equilibrium enzyme is one with low activity compared with the activity of the other enzymes in the pathway. Conversely, a near-equilibrium enzyme has high activity compared with other enzymes in the pathway. Belonging to one or other class of enzymes has important consequences in terms of variations in the concentration of the substrate or product of the reaction when the flux through the pathway varies. A large change in flux (such as that produced for instance by increasing the concentration from 5 to 20 mM glucose) can be accommodated by a near-equilibrium enzyme without a large change in substrate concentration. It implies that substrates of near-equilibrium reactions are unlikely to qualify as the metabolic signal. Conversely, substrates of non-equilibrium enzymes should vary substantially in response to flux changes and are thus more likely candidates.
Starting from glucose 6-phosphate, metabolites from different pathways can be considered: glycolysis and the formation of fructose 2,6-bisphosphate, mitochondrial oxidation of carbons arising from glycolysis, pentose phosphate pathway, glycogen synthesis, hexosamine pathway.
From the results obtained in vitro both in adipose tissue and hepatocytes, mitochondrial oxidation of carbons arising from glycolysis can clearly be ruled out. Indeed, the presence of a mixture of lactate and pyruvate in the culture medium has no effect on FAS, ACC or L-PK gene expression [ 18, 20, 25] . This is confirmed by the study of ACC expression in the pancreatic p-cell line, where substrates that are known to increase insulin secretion through their mitochondrial oxidation (leucine and glutamine) do not induce ACC expression [22] .
It has been suggested [32-341 that intermediates of the hexosamine pathway could be responsible for gene regulation in response to glucose in adipocytes and other tissues. The rate-limiting step of this pathway is glutamine-fructose-6-phosphate amidotransferase which catalyses the synthesis of glucosamine 6-phosphate from glutamine and fructose 6-phosphate and can be specifically inhibited by azaserine. Glucosamine 6-phosphate can also be formed through phosphorylation of glucosamine by hexokinase.
In cultured explants of adipocytes, glucosamine has no inductive effect on the FAS or ACC gene (F. Foufelle and P. Ferrt, unpub- lished work). In the pancreatic cell line [22] , glutamine has no stimulatory effect on ACC expression and glucosamine even antagonizes the glucose effect. Finally, in the case of the gene encoding L-PK, the stimulating effect of glucose on the L-PK mRNA in the p-cell line is fully preserved in the presence of azaserine and the effect of glucose can be obtained in a glutaminefree culture medium [24] . All these experiments argue against the involvement of the hexosamine-biosynthetic pathway in the glucose effect on lipogenic and glycolytic enzyme gene expression.
In in vitro studies, a number of glucose analogues have been tested, particularly Z-deoxyglucose. 2-Deoxyglucose is transported into cells by the same glucose transporters as glucose, and is phosphorylated by glucokinase and hexokinase. However, in contrast with glucose, it cannot be isomerized to fructose 6-phosphate and is a poor substrate for G-6-PDH (Vma relative to glucose 6-phosphate is 0.05) [35] . This leads to a large accumulation of 2-deoxyglucose 6-phosphate in the cell. In all tissues but the liver, 2-deoxyglucose 6-phosphate is a major product of 2-deoxyglucose metabolism with a minor product which may be UDP-2-deoxyglucose [36] .
In adipose-tissue explants, 2-deoxyglucose mimics the effect of glucose on FAS expression [18] . However, 1 mM 2-deoxyglucose is as efficient as 20 mM glucose. In the INS-1 pancreatic B-cell line, 2-deoxyglucose is able to induce both ACC and L-PK gene expression although to a lower extent than glucose [22, 24] . This suggests that 2-deoxyglucose 6-phosphate which accumulates in cells might be the signal metabolite and that, by extension, glucose 6-phosphate could be the natural signal for lipogenic enzyme expression.
It could be argued that, since 2-deoxyglucose 6-phosphate accumulates in the cell, it becomes an appreciable substrate for G-6-PDH despites its 20-fold lower dehydrogenation rate than glucose 6-phosphate. 6-Phosphogluconate could then be the signal metabolite. However, it has been shown previously that G-6-PDH activity, mRNA concentration and transcription rate are low in the liver and adipose tissue of suckling rats and starved adult rats [37-401 and that glucose 6-phosphate decarboxylation is barely detectable in suckling rat adipose tissue [ 151, suggesting that the pentose phosphate pathway from glucose does not operate. Moreover, after weaning on to a high-carbohydrate diet or after refeeding a starved rat with a highcarbohydrate diet, G-6-PDH transcription rate, mRNA concentration and activity are induced with a similar time course to that of FAS or ACC [40] . This suggests that 6-phosphogluconate is not the primary metabolite involved in the glucose effect.
In the liver, 2-deoxyglucose has been used with the same rationale to determine the metabolite involved, and no effect has been demonstrated on L-PK or FAS induction ( [41] ; C.
Prip-Buus, F. Foufelle, P. Ferrt and J. Girard, unpublished work). In the liver, 2-deoxyglucose 6-phosphate is a minor component of 2-deoxyglucose metabolism, since, after ion-exchange chromatography, products are found that are eluted in the triose phosphate region and may correspond to decarboxylated metabolites [ 361. Moreover, in the liver, a metabolite eluted close to UDP-glucose clearly accumulates. Thus the use of 2-deoxyglucose in hepatocytes is not valid to test the implication of hexose phosphate in a process. For the reasons given above, since there is no large accumulation of 2-deoxyglucose 6-phosphate in the liver, this would rather reinforce the idea that the hexose phosphate is the incriminated metabolite.
Concerning the glycogen pathway, glucose 6-phosphate is converted into glucose l-phosphate and then UDP-glucose. Glucose feeding in animals starved overnight produces a 4-fold increase in liver hexose 6-phosphate after 1 h but a 50% decrease in UDP-glucose [42] . In the perfused liver of 24 h-starved rats, increasing the glucose concentration in the perfusion medium from 2 to 30 mM increases glucose 6-phosphate concentration 1 0-fold without any increase in UDP-glucose [43] . This suggests that UDPglucose is an unlikely candidate. We have at the present time no argument to totally exclude glucose 1-phosphate from the potential list of candidates, in as much as 2-deoxyglucose 6-phosphate seems to be partially metabolized in the glycogen pathway.
Volume 24 Does glucose 6-phosphate meet all the requirements to be the signal metabolite?
Glucose 6-phosphate is the product of non-equilibrium enzymes (hexokinase, glucokinase) and it can be considered as the substrate of a nonequilibrium enzyme, 6-phosphofructo-1 -kinase, since glucose 6-phosphate and fructose 6-phosphate are in rapid equilibrium because of the high activity of phosphoglucose isomerase [31] . As such, its concentration varies in parallel with the external glucose concentration and in parallel with the induction of lipogenic enzyme expression (Figures 1 and 2 ).
An interesting study on the expression of L-PK has been performed in vivo, in the liver of starved adult rats re-fed with glucose or fructose, in which glycolytic intermediates were measured [ E l . Of the various glycolytic metabolites studied, only hexose 6-phosphate concentration varies in parallel with the rate of L-PK transcription, in contrast with fructose 1,6-bisphosphate, fructose 2,6-bisphosphate, phosphoenolpyruvate and fructose 1-phosphate.
Conclusions
In summary, the bulk of evidence suggests that glucose 6-phosphate is the signal metabolite in the induction of glycolytic/lipogenic enzyme expression: glucose needs to be phosphorylated to act as a signal for gene induction; substrates that are oxidized but do not enter glycolysis are not inducers; modulation of the carbon flux into the hexosamine pathway does not alter the effect of glucose, and glucosamine has no effect on lipogenic or glycolytic gene expression; the FAS gene can be induced in conditions in which the pentose phosphate pathway is inactive; 2-deoxyglucose mimics totally (adipose tissue explants) or partially (fl-cell line) the effect of glucose on lipogenic or glycolytic gene expression; in the liver, 2-deoxyglucose 6-phosphate does not accumulate and 2-deoxyglucose has no effect on gene expression; the intracellular concentration of glucose 6-phosphate varies in parallel with the intensity of gene induction; in vivo, the kinetics of the increase in hexose phosphate fit with the time-related pattern of gene induction whereas this is not the case for other glycolytic intermediates.
Nevertheless, the possibility that glucose 1-phosphate and fructose 6-phosphate are also involved cannot be ruled out. A knowledge of the target for the signal metabolite or genetic alterations of the various enzymes involved should allow us to differentiate between these possibilities. 
Introduction
T h e ability of insulin to regulate the transcription of specific genes is an important facet of homoeostatic control in vivo. Insulin almost certainly regulates the activity of trans-acting factors which bind to specific nucleotide elements within the promoter regions of these genes. Interestingly, insulin can both positively (e.g. glucokinase and fatty acid synthase) and negatively (e.g. phosphoenolpyruvate carboxykinase) regulate the expression of genes [l] . Any plausible hypothesis for a molecular mechanism must take this into account.
T h e past 5 years have seen the identification of several distinct insulin-response sequences within a number of promoters. Furthermore, during this time period, there have also been dramatic advances in our understanding of intracellular signalling pathways. Despite this, very little is known about the signalling pathways that are responsible for regulating the activity of these Abbreviations used: CAT, chloramphenicol acetyltransferase; CCD, charged couple device; CMV, trans-acting factors in response to insulin. cytomegalovirus; ERK, extracellular-signal-regulated T h e binding of insulin to its receptor inikinase; IRS, insulin receptor substrate; MAP, mitogen-activated protein; MEK, MAP kinase kinase, ERK tiates the activation of multiple parallel intrakinase; TRE, phorbol 12-myristate 13-acetatecellular signalling Pathways [21-A very early response element.
aspect of insulin signalling is the tyrosine phos-*To whom correspondence should be addressed.
phorylation not only of the receptor itself but
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